Pilot trial of preoperative (neoadjuvant) letrozole in combination with bevacizumab in postmenopausal women with newly diagnosed estrogen receptor- or progesterone receptor-positive breast cancer.
about
Ultrasound imaging of breast tumor perfusion and neovascular morphology.Predicting targeted drug combinations based on Pareto optimal patterns of coexpression network connectivityAntiangiogenic therapy for breast cancerEffect of targeted agents on the endocrine response of breast cancer in the neoadjuvant setting: a systematic review.The accuracy of (18)F-FDG PET/CT in predicting the pathological response to neoadjuvant chemotherapy in patients with breast cancer: a meta-analysis and systematic review.Bevacizumab plus preoperative chemotherapy in operable HER2 negative breast cancer: biomarkers and pathologic response.Phase III Trial Evaluating Letrozole As First-Line Endocrine Therapy With or Without Bevacizumab for the Treatment of Postmenopausal Women With Hormone Receptor-Positive Advanced-Stage Breast Cancer: CALGB 40503 (Alliance)Trials of bevacizumab in breast cancer--a safety review.The life, death, and attempted rebirth of bevacizumab in breast cancer.Implementing neoadjuvant endocrine strategies in ER-positive, HER2-negative breast cancer.Targeted adjuvant therapy in breast cancer.A phase III trial of exemestane plus bevacizumab maintenance therapy in patients with metastatic breast cancer after first-line taxane and bevacizumab: a GINECO group study.A Real-World Multicentre Retrospective Study of Paclitaxel-Bevacizumab and Maintenance Therapy as First-Line for HER2-Negative Metastatic Breast Cancer.
P2860
Q30375552-4DEBFC44-AF55-41E2-9EB5-3CD1595EA13BQ33772585-8C7A52FB-DE61-46A3-9A65-8CF0D278B98BQ34989039-0E5D0EDA-BBA3-4E53-B319-CC1F96A077D4Q35631641-24BF78F6-0609-4468-9B48-FF59384A079BQ36364739-EA4816A1-DCE6-46E2-AB4B-5D6CCA77F9CBQ37180350-F2C9CD99-FE38-4AEE-9CFE-E1E99E58EC0DQ37234829-E5F3F370-0820-4766-A5E8-31A01578E3E1Q37887823-F8B930CE-50E3-4A33-99BE-A175A81C0161Q38160648-A7591B38-B769-471B-BF10-B9A5726DBD8FQ38765017-CD5F0362-2AE0-4BB4-AFF3-19DCD4E4341BQ38980703-6CB67DF5-0A9A-4C12-94B5-C7CC3B7E51FBQ39967942-F0284A00-6550-4937-99F8-14205748A093Q51319007-9D75FC5D-3F1C-4058-9A74-62E5FA8FEC24
P2860
Pilot trial of preoperative (neoadjuvant) letrozole in combination with bevacizumab in postmenopausal women with newly diagnosed estrogen receptor- or progesterone receptor-positive breast cancer.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Pilot trial of preoperative (n ...... ceptor-positive breast cancer.
@ast
Pilot trial of preoperative (n ...... ceptor-positive breast cancer.
@en
type
label
Pilot trial of preoperative (n ...... ceptor-positive breast cancer.
@ast
Pilot trial of preoperative (n ...... ceptor-positive breast cancer.
@en
prefLabel
Pilot trial of preoperative (n ...... ceptor-positive breast cancer.
@ast
Pilot trial of preoperative (n ...... ceptor-positive breast cancer.
@en
P2093
P2860
P356
P1476
Pilot trial of preoperative (n ...... ceptor-positive breast cancer.
@en
P2093
Albert F LoBuglio
Andres Forero-Torres
Carla I Falkson
Cheryl F Jones
Helen Krontiras
Ivor J Percent
Janice A Galleshaw
Janis P O'Malley
Jatin J Shah
Jennifer F De Los Santos
P2860
P304
P356
10.3816/CBC.2010.N.035
P407
P577
2010-08-01T00:00:00Z